Should You Use Intraoperative Iodine in LEEP? New Trial

Gynecologic surgeons frequently utilize intraoperative Lugol's iodine during loop electrosurgical excision procedures (LEEP). Clinicians traditionally apply this Schiller test to delineate abnormal cervical epithelium and define surgical boundaries. However, robust evidence evaluating its actual benefit has long remained scarce. A landmark randomized controlled trial published in the American Journal of Obstetrics and Gynecology now challenges this long-standing clinical practice. The unexpected findings reveal that applying intraoperative Lugol's iodine actually increases the risk of positive resection margins.

Randomized Trial Design and Key Findings

Researchers conducted a prospective randomized trial across consecutive women referred to a colposcopy unit. Specifically, investigators randomized 229 patients to either LEEP with Lugol's iodine or LEEP without iodine staining. The primary endpoint assessed histopathological involvement of surgical margins.

Surprisingly, women in the intervention cohort experienced significantly higher margin involvement. Histopathological analysis confirmed positive margins in 17.5% of iodine cases compared to only 7.0% of control cases. Consequently, the relative risk of incomplete excision reached 2.52 in the staining arm. Multivariable logistic regression confirmed that staining independently elevated incomplete resection odds more than threefold.

Why Intraoperative Lugol's Iodine Compromises Excision Depth

To understand this counterintuitive outcome, researchers examined secondary specimen metrics. In particular, post hoc analysis demonstrated that iodine application resulted in a significantly shallower cone depth. The transformation-zone-adjusted mean cone depth was nearly 1.5 millimeters shallower in the iodine group.

Therefore, surgeons likely modify their excision trajectory when relying on surface Schiller staining. Visual changes on the ectocervix may distract the surgeon from maintaining adequate endocervical depth. Interestingly, other intraoperative parameters showed no significant variation between both trial arms. Operative duration, cone weight, specimen fragmentation, and surgeon satisfaction ratings remained statistically indistinguishable.

Postoperative Bleeding and Recovery Outcomes

Although oncologic margins suffered, iodine application did demonstrate modest secondary benefits. Specifically, patients in the staining cohort reported lower bleeding intensity during the first 24 postoperative hours. In addition, the overall duration of vaginal bleeding was shorter in the iodine cohort.

Nevertheless, overall patient satisfaction, pain scores, and analgesic requirements did not differ between the groups at day 14. Because incomplete excision carries long-term morbidity, minor bleeding improvements cannot outweigh oncologic failure. Persistent dysplasia requires intensive surveillance, repeat excisions, and elevated patient anxiety.

Practice Implications for Colposcopists and Gynecologists

In countries like India, cervical cancer screening and early lesion eradication remain paramount for public health. Consequently, clinicians must prioritize obtaining clear histopathological margins during excisional therapy through comprehensive clinical training. These new trial results provide clear direction against the routine intraoperative use of iodine during loop excision.

Instead, surgeons should rely on prior diagnostic colposcopy and careful morphological assessment of the transformation zone. Proper loop selection and adequate resection depth guarantee superior therapeutic efficacy. Thus, removing unnecessary intraoperative steps simplifies the surgical workflow while simultaneously improving disease clearance.

Frequently Asked Questions

Q1: Why did intraoperative Lugol's iodine increase the rate of positive margins?

The trial indicated that application of Lugol's iodine led to significantly shallower cone depths. Surgeons likely focused predominantly on surface ectocervical demarcation, inadvertently compromising adequate vertical endocervical resection depth.

Q2: Did intraoperative Lugol's iodine offer any clinical benefits?

Yes, patients in the iodine arm experienced reduced bleeding intensity in the first 24 hours and shorter bleeding duration. However, these minor recovery benefits do not justify the significantly higher risk of involved margins.

Q3: Should colposcopists stop using intraoperative iodine during LEEP?

Yes, the trial authors advise against routine intraoperative iodine staining during LEEP. Instead, practitioners should focus on thorough pre-procedural colposcopic mapping and achieving adequate excision geometry. Healthcare professionals looking to stay updated on best practices can explore specialized womens health educational resources.

References

1. Hecken JM et al. Loop electrosurgical excision procedure with or without intraoperative iodine: A randomized controlled trial. Am J Obstet Gynecol. 2026 Oct 26. doi: undefined. PMID: 42933750.
2. Grimm C et al. Innovative Diagnostic and Therapeutic Interventions in Cervical Dysplasia: A Systematic Review of Controlled Trials. Cancers (Basel). 2022;14(11):2670.
3. Arbyn M et al. Virologic versus cytologic triage of women with cervical intraepithelial neoplasia after local excisional treatment: a systematic review and meta-analysis. Lancet Oncol. 2017;18(9):e523-e535.